Sugammadex wraps Rocuronium in the bloodstream and carries it away, so Rocuronium never reaches the muscle nicotinic receptor at all.
This one is not a contest at a receptor. Sugammadex forms a tight complex with Rocuronium in the plasma; the complex is inactive and is cleared, so free Rocuronium falls and the receptor is simply left alone.
The point of the pair is reversal: it is given deliberately, and it works within minutes.
Nothing about Rocuronium’s own clearance changes — the drug is removed from where it could act.
This is a pharmacodynamic interaction. No level, AUC estimate or genotype would show it.



The ring marks the peg each drug wears for this receptor — the same cross-illumination Interact! draws when the two are put side by side.

